News IXICO plc

Stocks

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Delayed London S.E. 09:28:30 18/09/2026 BST			5-day change	1st Jan Change
7.150 ^GBX	-4.67%		-4.67%	-39.15%

07-13	Oil rises as Iran escalation keeps FTSE subdued	AN
07-13	Ixico notes ending of Huntington's disease programmes	AN

All News

Mentions Relevance

07-13	Ixico notes ending of Huntington's disease programmes	AN
07-13	WINNERS & LOSERS: Ixico lower order book; Pennant sees revenue jump	AN
07-13	Ixico Says Two Huntington's Disease Programs Discontinued by Sponsors	MT
07-07	IXICO plc Provides Earnings Guidance for the Year Ending 30 September 2026	CI
07-07	Ixico ups guidance; Steppe Cement revenue up	AN
06-08	Ixico plc Announces Appointments on Scientific Advisory Board	CI
06-08	Ixico Has Enters into A Research Collaboration with the Paris Brain Institute	CI
05-21	IXICO plc, H1 2026 Earnings Call, May 19, 2026
05-21	BTG to beat expectations; Sabre backs outlook	AN
05-21	Ixico Bags New Contract, Extension Worth GBP1.3 Million	MT
05-21	Ixico announces contract win & extension with total value of £1.3 million over 2 years	RE
05-21	Ixico plc Announces Contract Win and Extension	CI
05-19	Ixico reaffirms growth guidance as half-year revenue rises	AN
05-19	Ixico remains focused on delivering on guidance of 15% revenue growth for full year	RE
05-19	Earnings Flash (IXI.L) Ixico plc Reports Fiscal H1 Revenue GBP3.9M	MT
05-19	IXICO plc Reaffirms Earnings Guidance for the Full Year 2026	CI
05-19	IXICO plc Reports Earnings Results for the Half Year Ended March 31, 2026	CI
05-12	IXICO Plc Releases Latest Version Of AI-Driven Neuroimaging Technology Platform	CI
04-21	Ixico plc Provides Earnings Guidance for the First Half Ended 31 March 2026	CI
04-07	Ixico Completes Retail Stock Offering	MT
03-31	EARNINGS AND TRADING: Future takes "cautious view"; Ixico's fundraise	AN
03-31	Ixico Raises GBP10 Million via Share Placements, Subscription	MT
03-26	Ixico plc and Medidata Collaborate to Create Advanced Neuroimaging Clinical Trials Platform	CI
02-26	IXICO plc Presents Automated Capabilities to Measure Brain Volume Loss on Magnetic Resonance Imaging Within its IXI Platform	CI
02-12	IXICO plc Announces c.£1.5 Million Contract Extension on Global Phase 2 Clinical Trial	CI